This protocol is judged by an institutional critique board, an independent group that opinions any scientific trials involving human beings. If a study entails a Schedule I drug, once the board approves the protocol as moral, the scientists must make an application for an investigational new drug (IND) variety from the FDA.Prospects documented ver